Zobrazeno 1 - 10 of 160 pro vyhledávání: '"AM Hanby"'
3
Akademický článek
Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response.
Autor: Stevens W; Biomedical Imaging, University of Leeds, Leeds, UK., Farrow IM; Biomedical Imaging, University of Leeds, Leeds, UK., Georgiou L; Biomedical Imaging, University of Leeds, Leeds, UK.; Department of Medical Physics, German Oncology Center, Limassol, Cyprus., Hanby AM; School of Medicine, University of Leeds, Leeds, UK., Perren TJ; School of Medicine, University of Leeds, Leeds, UK., Windel LM; School of Medicine, University of Leeds, Leeds, UK., Wilson DJ; Dept of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Sharma N; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Dodwell D; Institute of Oncology, St. James's University Hospital, Leeds, UK.; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Hughes TA; School of Medicine, University of Leeds, Leeds, UK., Dall BJ; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Buckley DL; Biomedical Imaging, University of Leeds, Leeds, UK.
Publikováno v: The British journal of radiology [Br J Radiol] 2021 Jul 01; Vol. 94 (1123), pp. 20201396. Date of Electronic Publication: 2021 Jun 09.
Zobrazit plný text záznamu
4
Akademický článek
Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
Autor: Broad RV; School of Medicine, University of Leeds, Leeds, UK., Jones SJ; School of Medicine, University of Leeds, Leeds, UK.; Department of Breast Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Teske MC; School of Medicine, University of Leeds, Leeds, UK., Wastall LM; Department of Histopathology, St. James's University Hospital, Leeds, UK., Hanby AM; School of Medicine, University of Leeds, Leeds, UK.; Department of Histopathology, St. James's University Hospital, Leeds, UK., Thorne JL; School of Food Science and Nutrition, University of Leeds, Leeds, UK., Hughes TA; School of Medicine, University of Leeds, Leeds, UK. t.hughes@leeds.ac.uk.
Publikováno v: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (6), pp. 1110-1120. Date of Electronic Publication: 2021 Jan 04.
Zobrazit plný text záznamu
5
Akademický článek
Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.
Autor: Shaaban AM; Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. a.shaaban@bham.ac.uk., Hilton B; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Clements K; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Provenzano E; Addenbrookes Hospital, Cambridge, UK.; Cambridge Breast Unit, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Trust, Cambridge, UK., Cheung S; Screening Quality Assurance Service, Public Health England, Birmingham, UK., Wallis MG; Addenbrookes Hospital, Cambridge, UK.; Cambridge Breast Unit, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Trust, Cambridge, UK., Sawyer E; School of Cancer & Pharmaceutical Sciences, King's College London and Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK., Thomas JS; Western General Hospital, Edinburgh, UK., Hanby AM; Leeds Institute of Medical Research at St. James's, St James's University Hospital, Leeds, UK., Pinder SE; School of Cancer & Pharmaceutical Sciences, King's College London and Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK., Thompson AM; Baylor College of Medicine, Houston, TX, USA.
Publikováno v: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (5), pp. 1009-1017. Date of Electronic Publication: 2020 Nov 17.
Zobrazit plný text záznamu
6
Author Correction: Pan-cancer image-based detection of clinically actionable genetic alterations.
Autor: Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany. jkather@ukaachen.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. jkather@ukaachen.de.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany. jkather@ukaachen.de., Heij LR; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Department of Surgery, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands.; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Grabsch HI; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Loeffler C; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Echle A; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Muti HS; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Krause J; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Niehues JM; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Sommer KAJ; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Bankhead P; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Kooreman LFS; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., Schulte JJ; Department of Pathology, University of Chicago Medicine, Chicago, IL, USA., Cipriani NA; Department of Pathology, University of Chicago Medicine, Chicago, IL, USA., Buelow RD; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Boor P; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Ortiz-Brüchle N; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Hanby AM; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Speirs V; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Kochanny S; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Patnaik A; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Srisuwananukorn A; Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Brenner H; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., van den Brandt PA; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Jäger D; German Cancer Consortium (DKTK), Heidelberg, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Trautwein C; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany., Pearson AT; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA. apearson5@medicine.bsd.uchicago.edu., Luedde T; Division of Gastroenterology, Hepatology and Gastrointestinal Oncology, University Hospital RWTH Aachen, Aachen, Germany. tluedde@ukaachen.de.; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Duesseldorf, Germany. tluedde@ukaachen.de.
Publikováno v: Nature cancer [Nat Cancer] 2020 Nov; Vol. 1 (11), pp. 1129.
Zobrazit plný text záznamu
7
Akademický článek
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants.
Autor: Al Amri WS; School of Medicine, University of Leeds, Leeds, UK.; Department of Histopathology and Cytopathology, The Royal Hospital, Muscat, Oman., Baxter DE; School of Medicine, University of Leeds, Leeds, UK., Hanby AM; Department of Histopathology, St. James's University Hospital, Leeds, UK., Stead LF; School of Medicine, University of Leeds, Leeds, UK., Verghese ET; Department of Histopathology, St. James's University Hospital, Leeds, UK., Thorne JL; School of Food Science and Nutrition, University of Leeds, Leeds, UK., Hughes TA; School of Medicine, University of Leeds, Leeds, UK. t.hughes@leeds.ac.uk.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Oct; Vol. 183 (3), pp. 607-616. Date of Electronic Publication: 2020 Jul 30.
Zobrazit plný text záznamu
8
Akademický článek
Pan-cancer image-based detection of clinically actionable genetic alterations.
Autor: Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), Uni-versity Hospital Heidelberg, Heidelberg, Germany., Heij LR; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Department of Surgery, NUTRIM, School of Nutrition and Transla-tional Research in Metabolism, Maastricht University, Maastricht, The Netherlands.; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Grabsch HI; Department of Pathology, GROW School for Oncology and Develop-mental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Loeffler C; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Echle A; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Muti HS; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Krause J; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Niehues JM; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Sommer KAJ; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Bankhead P; MRC Institute of Genetics and Molecular Medicine, University of Ed-inburgh, Edinburgh, UK., Kooreman LFS; Department of Pathology, GROW School for Oncology and Develop-mental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Schulte JJ; Department of Pathology, University of Chicago Medicine, Chicago, IL, USA., Cipriani NA; Department of Pathology, University of Chicago Medicine, Chicago, IL, USA., Buelow RD; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Boor P; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Ortiz-Brüchle NN; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Hanby AM; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Speirs V; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Kochanny S; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Patnaik A; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Srisuwananukorn A; Department of Medicine, University of Illinois - Chicago, Chicago, IL, USA., Brenner H; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., van den Brandt PA; Department of Epidemiology, GROW School for Oncology and De-velopmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Jäger D; German Cancer Consortium (DKTK), Heidelberg, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), Uni-versity Hospital Heidelberg, Heidelberg, Germany., Trautwein C; Department of Medicine III, University Hospital RWTH Aachen, Aa-chen, Germany., Pearson AT; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Luedde T; Division of Gastroenterology, Hepatology and Gastrointestinal On-cology, University Hospital RWTH Aachen, Aachen, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseas-es, University Hospital Duesseldorf, Duesseldorf, Germany.
Publikováno v: Nature cancer [Nat Cancer] 2020 Aug; Vol. 1 (8), pp. 789-799. Date of Electronic Publication: 2020 Jul 27.
Zobrazit plný text záznamu
9
Akademický článek
Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.
Autor: Verma R; School of Medicine, University of Leeds, Leeds, UK.; Department of Breast Surgery, Bolton Hospital NHS Foundation Trust, Bolton, UK., Hanby AM; School of Medicine, University of Leeds, Leeds, UK.; Department of Histopathology, St. James's University Hospital, Leeds, UK., Horgan K; Department of Breast Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Verghese ET; Department of Histopathology, St. James's University Hospital, Leeds, UK., Volpato M; School of Medicine, University of Leeds, Leeds, UK., Carter CR; Department of Transplant Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Hughes TA; School of Medicine, University of Leeds, Leeds, UK. t.hughes@leeds.ac.uk.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Aug; Vol. 183 (1), pp. 49-59. Date of Electronic Publication: 2020 Jun 23.
Zobrazit plný text záznamu
10
Akademický článek
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.
Autor: Al Amri WS; School of Medicine, University of Leeds, Leeds, United Kingdom.; Department of Histopathology and Cytopathology, The Royal Hospital, Muscat, Oman., Allinson LM; School of Medicine, University of Leeds, Leeds, United Kingdom., Baxter DE; School of Medicine, University of Leeds, Leeds, United Kingdom., Bell SM; School of Medicine, University of Leeds, Leeds, United Kingdom., Hanby AM; School of Medicine, University of Leeds, Leeds, United Kingdom.; Department of Histopathology, St. James's University Hospital, Leeds, United Kingdom., Jones SJ; Department of Breast Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Shaaban AM; Histopathology and Cancer Sciences, Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, United Kingdom., Stead LF; School of Medicine, University of Leeds, Leeds, United Kingdom., Verghese ET; Department of Histopathology, St. James's University Hospital, Leeds, United Kingdom., Hughes TA; School of Medicine, University of Leeds, Leeds, United Kingdom. t.hughes@leeds.ac.uk.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Mar; Vol. 19 (3), pp. 945-955. Date of Electronic Publication: 2019 Dec 26.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje